Delivering Prolonged Exposure Therapy via Videoconferencing During the COVID-19 Pandemic: An Overview of the Research and Special Considerations for Providers

J Trauma Stress. 2020 Aug;33(4):380-390. doi: 10.1002/jts.22573. Epub 2020 Aug 17.

Abstract

Leveraging technology to provide evidence-based therapy for posttraumatic stress disorder (PTSD), such as prolonged exposure (PE), during the COVID-19 pandemic helps ensure continued access to first-line PTSD treatment. Clinical video teleconferencing (CVT) technology can be used to effectively deliver PE while reducing the risk of COVID-19 exposure during the pandemic for both providers and patients. However, provider knowledge, experience, and comfort level with delivering mental health care services, such as PE, via CVT is critical to ensure a smooth, safe, and effective transition to virtual care. Further, some of the limitations associated with the pandemic, including stay-at-home orders and physical distancing, require that providers become adept at applying principles of exposure therapy with more flexibility and creativity, such as when assigning in vivo exposures. The present paper provides the rationale and guidelines for implementing PE via CVT during COVID-19 and includes practical suggestions and clinical recommendations.

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections* / epidemiology
  • Evidence-Based Medicine
  • Humans
  • Implosive Therapy
  • Mental Health Services*
  • Pandemics*
  • Pneumonia, Viral* / epidemiology
  • SARS-CoV-2
  • Stress Disorders, Post-Traumatic* / therapy
  • Telemedicine
  • Videoconferencing*